Connecting Canada's innovative digital health, life sciences and tech companies to the New England market, clients, partners, and investors.

Translating Physicians' "familiar thinking" into medical codes. A novel way to Improve Quality and Cost of Care with Fast, Intuitive and Accurate Coding.

Leading technology, financial, and market due diligence on early stage life science companies and providing recommendations for investment. Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments.

Innovative and exciting technology - breathalyzer for diabetes detection and monitoring, pain-free. ​​Making lives better, one breath at a time​​.

Our group brings together the Romanian bio-medical community in the USA, Canada, Europe and everywhere else on the globe, raises awareness about our members from academia, healthcare and industry, improves communication, identifies collaborations and ultimately builds a strong network of relationships.

Healthcare strategy consulting firm focusing on healthcare services, health IT, and pharmaceuticals.

Market leader providing a portfolio of best-in-class technologies, services, and training in environmental infection prevention and control for the healthcare market.

Boston Technology Research is a Boston-headquartered dynamic company providing innovative regulatory compliance methodology, software tools and services for the Life Sciences industry.

Employee no. 1, key part of the team that raised over $20M and cleared the MoMe™ System, a remote cardiac monitoring device for arrhythmia detection in both the US and EU markets.

• Directed projects in lipid signaling, diabetic autonomic neuropathy, gender-specific effects of diabetes, and angiogenesis• Introduced novel techniques (mouse Langendorff perfusion, cardiac adenovirus delivery via atrial painting, real-time PCR, reporter assays) and initiated new research directions for the laboratory

• Led the construction of over 50+ viruses for laboratory and animal experimental use, introduced the newest techniques, and reduced production costs by 25% and the total process time by 50%• Trained and mentored investigators and collaborators in virus techniques and advised on experimental design

• Uncovered a critical link between lipid metabolism and parasympathetic control of the heart rate, suggesting a potential anti-arrhythmic role for cholesterol-lowering drugs • Co-Investigator, NIH Exploratory/Development Research Grant Award (R21) (2009-2011) • Recipient of the ASBMB Graduate/Postdoctoral Travel Award – Experimental Biology (2007)

• Part of the team who discovered a protein-protein interaction that is essential for vascular tone regulation• Identified a novel co-regulator of estrogen actions in the cardiovascular system

• Identified new business development opportunities to drive market growth for the cell culture business

• Evaluated the market potential and recommended the path to commercialization for novel gene therapies out of BIDMC.

• Defined the key value proposition and business model, researched the market, identified potential partners for academia start-ups